"The John A. Moran Eye Center provides the most comprehensive eye care in the Mountain West, with more than 35 specialists and 11 convenient locations offering a full range of leading-edge treatments. Our research labs are translating discoveries into new therapies for diseases including glaucoma and age-related macular degeneration, while our highly competitive education program ranks among the nation’s best."

During the past decade, University of Utah John A. Moran Eye Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 11 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah John A. Moran Eye Center" #1 sponsor was "University of Utah" with 16 trials, followed by "Jaeb Center for Health Research" with 5 trials sponsored, "JHSPH Center for Clinical Trials" with 4 trials sponsored, "National Eye Institute (NEI)" with 4 trials sponsored and "4D Molecular Therapeutics" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah John A. Moran Eye Center" #1 collaborator was "National Eye Institute (NEI)" with 11 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 3 trials as a collaborator, "Foundation Fighting Blindness" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Massachusetts Eye and Ear Infirmary" with 2 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah John A. Moran Eye Center" are "Retinopathy of Prematurity" (5 trials), "Uveitis" (5 trials), "Age-Related Macular Degeneration" (3 trials), "Macular Degeneration" (3 trials) and "Macular Edema" (3 trials). Many other conditions were trialed in "University of Utah John A. Moran Eye Center" in a lesser frequency.

Most popular intervention types in "University of Utah John A. Moran Eye Center" are "Drug" (33 trials), "Other" (11 trials), "Procedure" (7 trials), "Biological" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "Placebo" (3 trials), "Sham" (3 trials), "Artisan Aphakia Intraocular Lens" (2 trials) and "SBK" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah John A. Moran Eye Center" are 59 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Utah John A. Moran Eye Center". 1 are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in University of Utah John A. Moran Eye Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah John A. Moran Eye Center, 9 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".